Status:
COMPLETED
Hidradenitis Suppurativa Wound Care
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Hidradenitis Suppurativa (HS)
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The objective of this case series is to monitor time and outcome of healing of wounds associated with HS using Endoform \[ovine forestomach\], Hydrofera Blue \[methylene blue and gentian violet\], and...
Detailed Description
Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory disease most frequently affecting the axilla, groin, and inframammary regions. Symptoms include nodules, abscesses, sinus tract...
Eligibility Criteria
Inclusion
- Individuals with hidradenitis suppurativa with non-healing wounds or draining abscesses/nodules
- Individuals over 18 years of age
Exclusion
- Individuals younger than 18 years of age
- Individuals without a diagnosis of HS
Key Trial Info
Start Date :
February 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04354012
Start Date
February 4 2021
End Date
August 28 2024
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Health Sciences Dermatology
Winston-Salem, North Carolina, United States, 27104